Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001

Conditions: Peanut Allergy Interventions: Drug: IGNX001; Drug: Placebo Sponsors: IgGenix Australia Pty Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials